Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-01-21

Clinical Trial Update: HCV Post-Exposure Prophylaxis for Health Care Workers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial studying Hepatitis C post-exposure prophylaxis for healthcare workers was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatitis C | Phase 4 | Status: WITHDRAWN